Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001828185-24-000085
Filing Date
2024-11-06
Accepted
2024-11-06 08:06:39
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brns-20240930.htm   iXBRL 10-Q 1148975
2 EX-10.1 leonhooftman-executiveserv.htm EX-10.1 196867
3 EX-31.1 brns-20240930xexx311.htm EX-31.1 11102
4 EX-31.2 brns-20240930xexx312.htm EX-31.2 11044
5 EX-32.2 brns-20240930xexx321.htm EX-32.2 6435
11 brns-20240930_g1.jpg GRAPHIC 619379
12 image_1.jpg GRAPHIC 5274
13 image_2a.jpg GRAPHIC 8178
  Complete submission text file 0001828185-24-000085.txt   6954998

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20240930.xsd EX-101.SCH 41402
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT brns-20240930_cal.xml EX-101.CAL 62978
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20240930_def.xml EX-101.DEF 173679
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20240930_lab.xml EX-101.LAB 505641
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20240930_pre.xml EX-101.PRE 336978
81 EXTRACTED XBRL INSTANCE DOCUMENT brns-20240930_htm.xml XML 528167
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 241429320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)